Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today ...

As the world celebrates the 2025 International Year of Quantum Science and Technology, it’s natural that we should focus on ...

Berlin: Bayer has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...

NIIMS Hospital continues to provide affordable healthcare under Ayushman Bharat and the Central Government Health Scheme ...